Friday, September 9, 2016

BRIEF-Medivir reports positive phase IIa data for simeprevir

* Interim results from phase IIa trial evaluating triple

combination including simeprevir demonstrates high level of

efficacy in HCV patients

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)